Cardiac and Renal Biomarkers in Arthroplasty Surgery

NCT03940651 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 1

Last updated 2021-02-05

No results posted yet for this study

Summary

The investigators will compare the effect of spinal anesthesia to general anesthesia on the level of high sensitivity cardiac biomarkers in patients undergoing hip or knee arthroplasty. The investigators will also measure renal biomarkers in urine to evaluate kidney injury in the postoperative period.

Conditions

  • Renal Injury
  • Anesthesia
  • Myocardial Injury
  • Arthropathy of Knee
  • Arthropathy of Hip

Interventions

DRUG

Spinal Anesthesia

Patients will be randomized to type of anesthesia

DRUG

General Anesthetics

Patients will be randomized to type of anesthesia

Sponsors & Collaborators

  • Abbott

    collaborator INDUSTRY
  • BioMérieux

    collaborator INDUSTRY
  • Washington University School of Medicine

    lead OTHER

Principal Investigators

  • Mohammad Helwani, MD · Washington University School of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-09-04
Primary Completion
2020-09-23
Completion
2020-09-23

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03940651 on ClinicalTrials.gov